title: Perspectives in immunopharmacology: the future of immunosuppression.
abstract: Modulation of immune responses for therapeutic purposes is a particularly relevant area, given the central role of anomalous immunity in a wide variety of diseases, from the most typically immune-related syndromes (autoimmune diseases, allergy and asthma, immunodeficiencies) to those in which altered immunity and inflammation define the pathological outcomes (chronic infections, tumors, chronic inflammatory and degenerative diseases, metabolic disorders, etc.). This brief review will summarize some of the most promising perspectives of immunopharmacology, in particular in the area of immunosuppression, by considering the following aspects:
authors: National Research Council, Institute of Protein Biochemistry, Napoli, Italy. Electronic address: diana.boraschi@gmail.com.
authors: Diana
authors: D
authors: Boraschi
authors: Center for Genetic Engineering and Biotechnology, Havana City, Cuba.
authors: Giselle
authors: G
authors: Penton-Rol
mesh_terms: D001688:Biological Products / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007154:Immune System Diseases / Q000188:drug therapy / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D007109:Immunity / Q000187:drug effects* / Q000502:physiology*; D056747:Immunomodulation / Q000187:drug effects* / Q000235:genetics; D007165:Immunosuppression Therapy; D064307:Microbiota / Q000276:immunology; D050997:Nanomedicine; D057285:Precision Medicine
chemical_list: D001688:Biological Products
keywords: Immunopharmacology; Immunosuppression; Microbiome; Nanomedicine; Personalized medicine